Attached files

file filename
EX-10.282 - RRA 7.25% 2022 NOTES - Endo International plcex10282-endorracounterpart.htm
EX-10.278 - RRA 2019 NOTES - Endo International plcex10278-endoxrracounterpar.htm
EX-10.291 - RRA 2020 NOTES - Endo International plcex10291-endo_xxrraxcounter.htm
EX-10.287 - RRA 2025 NOTES - Endo International plcex10287-endo_rraxcounterpa.htm
EX-10.279 - SUPPLEMENTAL INDENTURE 2020 NOTES - Endo International plcex10279-endosupplementalin.htm
EX-10.288 - SUPPLEMENTAL INDENTURE 2019 NOTES - Endo International plcex10288-endo_supplementalx.htm
EX-10.277 - SUPPLEMENTAL INDENTURE 2019 NOTES - Endo International plcex10277-endoxsuppindenture.htm
EX-10.292 - SUPPLEMENTAL INDENTURE 5.75% 2022 NOTES - Endo International plcex10292-endo_xxsupplementa.htm
EX-10.285 - RRA 2023 NOTES - Endo International plcex10285-endo_rraxcounterpa.htm
EX-10.293 - SUPPLEMENTAL INDENTURE 7.25% 2022 NOTES - Endo International plcex10293-endo_xxsupplementa.htm
EX-10.289 - RRA 2019 NOTES - Endo International plcex10289-endo_rraxcounterpa.htm
EX-10.297 - SUPPLEMENTAL INDENTURE 2025 NOTES - Endo International plcex10297-endo_xxsupplementa.htm
EX-10.283 - SUPPLEMENTAL INDENTURE 5.75% 2022 NOTES - Endo International plcex10283-endosupplementalin.htm
EX-10.280 - RRA 2020 NOTES - Endo International plcex10280-endorracounterpart.htm
EX-10.298 - RRA 2025 NOTES - Endo International plcex10298-endo_xxrraxcounter.htm
EX-10.296 - RRA 2023 NOTES - Endo International plcex10296-endo_xxrraxcounter.htm
EX-10.284 - SUPPLEMENTAL INDENTURE 2023 NOTES - Endo International plcex10284-endo_supplementalx.htm
EX-10.290 - SUPPLEMENTAL INDENTURE 2020 NOTES - Endo International plcex10290-endo_xxsupplementa.htm
EX-10.286 - SUPPLEMENTAL INDENTURE 2025 NOTES - Endo International plcex10286-endo_supplementalx.htm
EX-10.295 - SUPPLEMENTAL INDENTURE 2023 NOTES - Endo International plcex10295-endo_xxsupplementa.htm
EX-10.281 - SUPPLEMENTAL INDENTURE 7.25% 2022 NOTES - Endo International plcex10281-endosupplementalin.htm
EX-10.294 - RRA 7.25% 2022 NOTES - Endo International plcex10294-endo_xxrraxcounter.htm
EX-31.1 - CEO SECTION 302 CERTIFICATION - Endo International plcex3116302015ceo302cert.htm
EX-32.1 - CEO SECTION 906 CERTIFICATION - Endo International plcex3216302015ceo906cert.htm
EX-32.2 - CFO SECTION 906 CERTIFICATION - Endo International plcex3226302015cfo906cert.htm
EX-21 - SUBSIDIARIES - Endo International plcex216302015subsidiaries.htm
EX-10.276 - ENDO 2015 PLAN - MATCHED PERFORMANCE AWARD - Endo International plcex10276endo_2015xplanxmatc.htm
EX-10.275 - ENDO 2015 PLAN - PSU AGREEMENT - Endo International plcex10275endo_2015xplanxpsux.htm
EX-10.274 - ENDO 2015 PLAN - RSU AGREEMENT - Endo International plcex10274endo_2015xplanxrsux.htm
10-Q - 10-Q - Endo International plcendp-6302015x10q.htm
EX-10.19.3 - UPS SECOND AMENDMENT TO MSA - Endo International plcex10193-upssecondamendment.htm
EX-10.273 - ENDO 2015 PLAN - OPTION AGREEMENT - Endo International plcex10273endo_2015xplanxopti.htm
Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002
I, Suketu P. Upadhyay, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Endo International plc;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s Board of Directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
/S/ SUKETU P. UPADHYAY
Suketu P. Upadhyay
Executive Vice President, Chief Financial Officer
(Principal Financial Officer)
 
 
Date:
August 10, 2015